Wolverine Trading, LLC Protalix Bio Therapeutics, Inc. Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	BUY	$2.0 - $3.36 $34,416 - $57,818	17,208 New	17,208 $34,000
Q3 2021 Nov 12, 2021	SELL	$1.31 - $1.87 $22,450 - $32,048	-17,138 Reduced 37.83%	28,168 $39,000
Q2 2021 Aug 06, 2021	BUY	$1.86 - $6.22 $49,304 - $164,879	26,508 Added 141.02%	45,306 $87,000
Q1 2021 May 14, 2021	BUY	$3.58 - $6.45 $28,353 - $51,084	7,920 Added 72.81%	18,798 $85,000
Q4 2020 Feb 12, 2021	BUY	$3.15 - $3.98 $34,265 - $43,294	10,878 New	10,878 $38,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $91M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.